Income Statement PCL, Inc.

Stocks

A241820

KR7241820000

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 21/03/2025			5-day change	1st Jan Change
6,040.00 ^KRW	-1.63%		-.--%	-

30/12/24	Yeom Ju-hwan agreed to acquire 36.90% stake in mCureX Therapeutics, Inc. from PCL, Inc. for KRW 13.0 billion.	CI
30/08/24	PCL, Inc. announced that it has received KRW 4.004999835 billion in funding	CI

3b585adc.Z1uxhDfehy9x7eD-G6t7MmXvpBeWn3aUSsEDgTqDILI.HhLdqXGR7HcQstGsK8hWWw-__iXC0BjaHbRm0l3WeuYJKu7dQ7rPdwOUuQ

Published financial data: PCL, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	53.68B	46.15B	37.22B	8.43B	1.25B
Other Revenues, Total	-	-	-10	-	10
Total Revenues	53.68B	46.15B	37.22B	8.43B	1.25B
Cost of Goods Sold, Total	18.97B	57.33B	30.42B	11.51B	11.56B
Gross Profit	34.71B	-11.18B	6.8B	-3.08B	-10.31B
Selling General & Admin Expenses, Total	4.19B	7.65B	10.63B	6.18B	11.11B
Provision for Bad Debts	-	1.5B	361M	4.31B	3.46B
R&D Expenses	4.21B	4.83B	3.5B	1.72B	1.41B
Depreciation & Amortization - (IS)	592M	484M	509M	965M	872M
Amortization of Goodwill and Intangible Assets - (IS)	41.4M	133M	106M	110M	74.62M
Other Operating Expenses, Total	9.04B	14.59B	15.1B	13.29B	16.93B
Operating Income	25.68B	-25.77B	-8.3B	-16.37B	-27.24B
Interest Expense, Total	-387M	-2.98B	-4.22B	-2.5B	-1.2B
Interest And Investment Income	6.01M	161M	1.37B	664M	567M
Net Interest Expenses	-381M	-2.82B	-2.85B	-1.83B	-636M
Income (Loss) On Equity Invest.	-	-	-	-1.22B	-11.04B
Currency Exchange Gains (Loss)	-76.67M	665M	-35.44M	295M	509M
Other Non Operating Income (Expenses)	-5.76B	-2.88B	6.91B	2.3B	-2.88B
EBT, Excl. Unusual Items	19.46B	-30.8B	-4.28B	-16.83B	-41.28B
Gain (Loss) On Sale Of Investments	49.59M	-867M	-	85M	131M
Gain (Loss) On Sale Of Assets	-	-	270M	-13.42M	-
Asset Writedown	-	-	-	-61.94M	-11.69B
Other Unusual Items	-	-	-	-3.54B	-
EBT, Incl. Unusual Items	19.51B	-31.67B	-4.01B	-20.37B	-52.84B
Income Tax Expense	-	-	-	-81.44M	-505K
Earnings From Continuing Operations	19.51B	-31.67B	-4.01B	-20.28B	-52.84B
Net Income to Company	19.51B	-31.67B	-4.01B	-20.28B	-52.84B
Minority Interest	-	2.9M	-6.31M	-34.05M	505M
Net Income - (IS)	19.51B	-31.67B	-4.02B	-20.32B	-52.34B
Net Income to Common Incl Extra Items	19.51B	-31.67B	-4.02B	-20.32B	-52.34B
Net Income to Common Excl. Extra Items	19.51B	-31.67B	-4.02B	-20.32B	-52.34B
Per Share Items
Net EPS - Basic	13.54K	-20.85K	-2.54K	-10.01K	-18.64K
Basic EPS - Continuing Operations	13.54K	-20.85K	-2.54K	-10.01K	-18.64K
Basic Weighted Average Shares Outstanding	1.44M	1.52M	1.58M	2.03M	2.81M
Net EPS - Diluted	13.12K	-20.85K	-2.54K	-10.01K	-18.64K
Diluted EPS - Continuing Operations	13.12K	-20.85K	-2.54K	-10.01K	-18.64K
Diluted Weighted Average Shares Outstanding	1.52M	1.52M	1.58M	2.03M	2.81M
Normalized Basic EPS	8.44K	-12.67K	-1.7K	-5.2K	-9.01K
Normalized Diluted EPS	8.01K	-12.67K	-1.7K	-5.2K	-9.01K
Supplemental Items
EBITDA	27.03B	-23.73B	-5.72B	-13.5B	-24.68B
EBITA	25.72B	-25.63B	-8.2B	-16.26B	-27.16B
EBIT	25.68B	-25.77B	-8.3B	-16.37B	-27.24B
Effective Tax Rate - (Ratio)	-	-	-	0.4	0
Normalized Net Income	12.16B	-19.25B	-2.68B	-10.56B	-25.3B
Supplemental Operating Expense Items
Advertising Expense	37.5M	70.57M	622M	165M	96.79M
Selling and Marketing Expenses	1.87B	5.09B	7.85B	3.62B	6.81B
General and Administrative Expenses	33.29M	30.68M	39.8M	10.64M	51.17M
Research And Development Expense From Footnotes	4.21B	4.83B	3.5B	1.72B	1.41B
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-219M	7.13M
Total Stock-Based Compensation	-	-	-	-219M	7.13M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	4.18B	38.22B	26.13B	7B	2.06B
Short Term Investments	2M	2M	6.34B	4.8B	1.9B
Total Cash And Short Term Investments	4.18B	38.22B	32.47B	11.8B	3.96B
Accounts Receivable, Total	519M	1.69B	4.06B	7.22B	3.1B
Other Receivables	174M	61.82M	3.41B	553M	14.21M
Notes Receivable	-	-	-	2.4B	120M
Total Receivables	693M	1.75B	7.47B	10.17B	3.23B
Inventory	27.41B	21.72B	18.04B	9.52B	134M
Prepaid Expenses	605M	391M	282M	28.9M	186M
Other Current Assets, Total	3.07B	1.66B	368M	336M	278M
Total Current Assets	35.96B	63.74B	58.62B	31.85B	7.79B
Gross Property Plant And Equipment	10.48B	19.16B	21.52B	17.83B	2.15B
Accumulated Depreciation	-3.57B	-5.02B	-6.8B	-8.37B	-577M
Net Property Plant And Equipment	6.9B	14.14B	14.72B	9.46B	1.58B
Long-term Investments	-	500M	13B	11.76B	5.2B
Other Intangibles, Total	104M	291M	325M	216M	-
Accounts Receivable Long-Term	400	400	450	-	-
Other Long-Term Assets, Total	593M	624M	1.26B	8.9B	7.01B
Total Assets	43.56B	79.3B	87.94B	62.19B	21.58B
Liabilities
Accounts Payable, Total	193M	1.22B	1.76B	60.25M	66.84M
Accrued Expenses, Total	179M	264M	505M	461M	305M
Short-term Borrowings	3.02B	14.3B	25.4B	15.14B	7.88B
Current Portion of Long-Term Debt	90	-	-180	-	-
Current Portion of Leases	298M	289M	581M	489M	409M
Other Current Liabilities	2.35B	26.33B	20.05B	4.45B	2.46B
Total Current Liabilities	6.05B	42.4B	48.29B	20.6B	11.12B
Long-Term Debt	-	15.36B	4.8B	3.15B	2.45B
Long-Term Leases	54.42M	94.32M	411M	223M	249M
Deferred Tax Liability Non Current	-	-	-	54.78M	51.07M
Other Non Current Liabilities	710M	942M	798M	553M	593M
Total Liabilities	6.81B	58.8B	54.29B	24.58B	14.46B
Preferred Stock Redeemable	-	3.87B	-	-	-
Total Preferred Equity	-	3.87B	-	-	-
Common Stock, Total	5.04B	5.18B	5.98B	25.76B	29.59B
Additional Paid In Capital	35.42B	44.45B	64.64B	68.12B	88.29B
Retained Earnings	-3.84B	-35.51B	-39.53B	-59.85B	-112B
Comprehensive Income and Other	133M	432M	472M	1.46B	1.43B
Total Common Equity	36.75B	14.55B	31.56B	35.49B	7.12B
Minority Interest	-	2.08B	2.09B	2.12B	-
Total Equity	36.75B	20.5B	33.64B	37.61B	7.12B
Total Liabilities And Equity	43.56B	79.3B	87.94B	62.19B	21.58B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.51M	1.56M	1.79M	2.58M	2.96M
ECS Total Common Shares Outstanding	1.51M	1.56M	1.79M	2.58M	2.96M
Book Value / Share	24.31K	9.35K	17.59K	13.78K	2.41K
Tangible Book Value	36.65B	14.26B	31.23B	35.27B	7.12B
Tangible Book Value Per Share	24.24K	9.17K	17.41K	13.69K	2.41K
Total Debt	3.38B	30.04B	31.18B	19.01B	10.99B
Net Debt	-804M	-8.18B	-1.29B	7.2B	7.03B
Minority Interest, Total (Incl. Fin. Div)	-	2.08B	2.09B	2.12B	-
Equity Method Investments, Total	-	-	13B	11.76B	-
Inventories - Raw Materials, Total	16.32B	19.29B	17.6B	17.3B	17.36B
Inventories - Finished Goods, Total	11.09B	13.88B	16.82B	12.15B	9.82B
Inventories - Others	260	-390	310	200	210
Land - (BS)	996M	2.9B	2.78B	1.1B	1.06B
Buildings, Total	1.8B	5.82B	5.53B	747M	747M
Machinery, Total	5.85B	8.48B	9.98B	12.68B	348M
Accumulated Allowance for Doubtful Accounts (Supple)	137M	1.63B	1.7B	5.77B	9.1B

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	19.51B	-31.67B	-4.02B	-20.32B	-52.34B
Depreciation & Amortization - CF	1.31B	1.9B	2.48B	2.76B	2.49B
Amortization of Goodwill and Intangible Assets - (CF)	41.4M	133M	106M	110M	74.62M
Depreciation & Amortization, Total	1.35B	2.03B	2.59B	2.87B	2.56B
(Gain) Loss From Sale Of Asset	-	-	-270M	13.42M	749M
(Gain) Loss on Sale of Investments - (CF)	-49.59M	867M	-	-85M	5.14B
Asset Writedown & Restructuring Costs	-	-	-	61.94M	6.42B
(Income) Loss On Equity Investments - (CF)	-	-	-	1.22B	10.29B
Stock-Based Compensation (CF)	84.61M	336M	80.07M	-219M	7.13M
Provision and Write-off of Bad Debts	-	1.5B	303M	4.07B	3.33B
Other Operating Activities, Total	6.24B	18.77B	1.15B	6.15B	5.79B
Change In Accounts Receivable	-551M	-2.54B	-2.51B	-7.18B	1.26B
Change In Inventories	-27.35B	-8.3B	-1.25B	4.96B	2.27B
Change In Accounts Payable	193M	993M	577M	-	6.59M
Change In Deferred Taxes	-	-	-	505K	-
Change in Other Net Operating Assets	-1.72B	1.79B	2.36B	3.54B	-1.27B
Cash from Operations	-2.29B	-16.22B	-995M	-4.92B	-15.78B
Capital Expenditure	-2.83B	-6.6B	-2.77B	-3.26B	-128M
Sale of Property, Plant, and Equipment	-	-	686M	197M	-
Divestitures	-	-	-	-	311M
Sale (Purchase) of Real Estate properties	-	-1.9B	203M	-	-
Sale (Purchase) of Intangible assets	-1.16M	-184M	-38.08M	-1M	-7.65M
Investment in Marketable and Equity Securities, Total	8.07B	-500M	-19.06B	1.62B	-4.64B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-2.4B	-
Other Investing Activities, Total	-10	-	72M	10	8M
Cash from Investing	5.24B	-9.19B	-20.91B	-3.84B	-4.45B
Short Term Debt Issued, Total	4.2B	35.7B	3.6B	4.92B	8.1B
Long-Term Debt Issued, Total	-	41.32B	-	7.9B	-
Total Debt Issued	4.2B	77.02B	3.6B	12.82B	8.1B
Short Term Debt Repaid, Total	-4.2B	-22.7B	-5.6B	-10.32B	-16.06B
Long-Term Debt Repaid, Total	-302M	-472M	-986M	-36.15B	-696M
Total Debt Repaid	-4.5B	-23.17B	-6.59B	-46.47B	-16.76B
Issuance of Common Stock	103M	176M	12.3B	23.31B	24B
Issuance of Preferred Stock	-	3B	-	-	-
Other Financing Activities, Total	-1.6M	2.12B	-72.74M	-20.66M	-55.28M
Cash from Financing	-201M	59.14B	9.24B	-10.36B	15.29B
Foreign Exchange Rate Adjustments	-46.99M	316M	569M	-664K	-3.94M
Net Change in Cash	2.71B	34.04B	-12.09B	-19.13B	-4.94B
Supplemental Items
Cash Interest Paid	53.92M	565M	635M	1.5B	1.15B
Cash Income Tax Paid (Refund)	4.12M	9.3M	20.84M	41.22M	-22.18M
Levered Free Cash Flow	-	8.63B	-14.19B	-23.64B	-1.26B
Unlevered Free Cash Flow	-	10.49B	-11.55B	-22.08B	-507M
Change In Net Working Capital	-	-31.35B	6.14B	11.24B	-14.08B
Net Debt Issued / Repaid	-302M	53.85B	-2.99B	-33.65B	-8.66B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-	-26.22	-6.21	-13.63	-40.64
Return on Total Capital	-	-35.52	-9	-16.85	-45.57
Return On Equity %	-	-110.65	-14.82	-56.93	-236.3
Return on Common Equity	-	-123.47	-17.43	-60.61	-245.68
Margin Analysis
Gross Profit Margin %	64.66	-24.22	18.28	-36.58	-827.34
SG&A Margin	7.81	16.58	28.55	73.33	891.67
EBITDA Margin %	50.35	-51.43	-15.36	-160.21	-1.98K
EBITA Margin %	47.91	-55.55	-22.03	-192.9	-2.18K
EBIT Margin %	47.83	-55.83	-22.31	-194.2	-2.19K
Income From Continuing Operations Margin %	36.34	-68.63	-10.78	-240.63	-4.24K
Net Income Margin %	36.34	-68.63	-10.79	-241.03	-4.2K
Net Avail. For Common Margin %	36.34	-68.63	-10.79	-241.03	-4.2K
Normalized Net Income Margin	22.66	-41.71	-7.21	-125.22	-2.03K
Levered Free Cash Flow Margin	-	18.7	-38.12	-280.5	-100.97
Unlevered Free Cash Flow Margin	-	22.74	-31.04	-261.99	-40.68
Asset Turnover
Asset Turnover	-	0.75	0.45	0.11	0.03
Fixed Assets Turnover	-	4.39	2.58	0.7	0.23
Receivables Turnover (Average Receivables)	-	41.76	12.95	1.5	0.24
Inventory Turnover (Average Inventory)	-	2.33	1.53	0.84	2.4
Short Term Liquidity
Current Ratio	5.95	1.5	1.21	1.55	0.7
Quick Ratio	0.81	0.94	0.83	0.95	0.64
Operating Cash Flow to Current Liabilities	-0.38	-0.38	-0.02	-0.24	-1.42
Days Sales Outstanding (Average Receivables)	-	8.74	28.19	244.11	1.51K
Days Outstanding Inventory (Average Inventory)	-	156.4	238.53	436.75	152.8
Average Days Payable Outstanding	-	5	20.33	110.74	10.7
Cash Conversion Cycle (Average Days)	-	160.14	246.39	570.12	1.66K
Long Term Solvency
Total Debt/Equity	9.19	146.57	92.68	50.54	154.41
Total Debt / Total Capital	8.42	59.44	48.1	33.57	60.69
LT Debt/Equity	0.15	75.42	15.47	8.97	37.93
Long-Term Debt / Total Capital	0.14	30.59	8.03	5.96	14.91
Total Liabilities / Total Assets	15.63	74.15	61.74	39.53	67.02
EBIT / Interest Expense	66.35	-8.64	-1.97	-6.56	-22.66
EBITDA / Interest Expense	69.84	-7.96	-1.35	-5.41	-20.53
(EBITDA - Capex) / Interest Expense	62.53	-10.18	-2.01	-6.72	-20.63
Total Debt / EBITDA	0.12	-1.27	-5.45	-1.41	-0.45
Net Debt / EBITDA	-0.03	0.34	0.22	-0.53	-0.28
Total Debt / (EBITDA - Capex)	0.14	-0.99	-3.67	-1.13	-0.44
Net Debt / (EBITDA - Capex)	-0.03	0.27	0.15	-0.43	-0.28
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-14.04	-19.35	-77.35	-85.22
Gross Profit, 1 Yr. Growth %	-	-132.2	-160.85	-145.34	234.32
EBITDA, 1 Yr. Growth %	-	-187.82	-75.91	136.21	82.72
EBITA, 1 Yr. Growth %	-	-199.67	-68.02	98.36	67.06
EBIT, 1 Yr. Growth %	-	-200.35	-67.77	97.16	66.39
Earnings From Cont. Operations, 1 Yr. Growth %	-	-262.35	-87.34	405.68	160.52
Net Income, 1 Yr. Growth %	-	-262.33	-87.31	405.73	157.6
Normalized Net Income, 1 Yr. Growth %	-	-258.28	-86.07	293.5	139.67
Diluted EPS Before Extra, 1 Yr. Growth %	-	-258.99	-87.81	293.51	86.33
Accounts Receivable, 1 Yr. Growth %	-	225.7	139.99	77.85	-57.1
Inventory, 1 Yr. Growth %	-	-20.78	-16.94	-47.24	-98.6
Net Property, Plant and Equip., 1 Yr. Growth %	-	104.74	4.16	-35.73	-83.33
Total Assets, 1 Yr. Growth %	-	82.04	10.9	-29.28	-65.31
Tangible Book Value, 1 Yr. Growth %	-	-61.09	119.05	12.94	-79.83
Common Equity, 1 Yr. Growth %	-	-60.41	116.91	12.46	-79.95
Cash From Operations, 1 Yr. Growth %	-	609.52	-93.87	394.11	220.89
Capital Expenditures, 1 Yr. Growth %	-	133.37	-58.04	17.66	-96.08
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-264.42	67.59	-94.68
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-210.09	92.52	-97.7
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-16.74	-57.26	-81.7
Gross Profit, 2 Yr. CAGR %	-	-	-55.74	-47.47	23.12
EBITDA, 2 Yr. CAGR %	-	-	-54.01	-24.57	107.75
EBITA, 2 Yr. CAGR %	-	-	-43.54	-20.36	82.04
EBIT, 2 Yr. CAGR %	-	-	-43.13	-20.29	81.12
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	-54.66	-19.97	262.96
Net Income, 2 Yr. CAGR %	-	-	-54.62	-19.9	260.94
Normalized Net Income, 2 Yr. CAGR %	-	-	-53.04	-25.95	207.1
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-55.97	-30.73	170.78
Accounts Receivable, 2 Yr. CAGR %	-	-	179.58	106.6	-12.65
Inventory, 2 Yr. CAGR %	-	-	-18.88	-33.8	-91.39
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	46.03	-18.18	-67.27
Total Assets, 2 Yr. CAGR %	-	-	42.08	-11.44	-50.47
Tangible Book Value, 2 Yr. CAGR %	-	-	-7.68	57.29	-52.27
Common Equity, 2 Yr. CAGR %	-	-	-7.33	56.19	-52.51
Cash From Operations, 2 Yr. CAGR %	-	-	-34.03	-44.95	298.19
Capital Expenditures, 2 Yr. CAGR %	-	-	-1.05	-29.74	-78.52
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	65.52	-70.14
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	45.08	-78.98
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	-46.05	-70
Gross Profit, 3 Yr. CAGR %	-	-	-	-55.38	-2.66
EBITDA, 3 Yr. CAGR %	-	-	-	-20.65	1.31
EBITA, 3 Yr. CAGR %	-	-	-	-14.17	1.95
EBIT, 3 Yr. CAGR %	-	-	-	-13.93	1.87
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	1.31	18.61
Net Income, 3 Yr. CAGR %	-	-	-	1.36	18.23
Normalized Net Income, 3 Yr. CAGR %	-	-	-	-4.61	9.53
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-8.63	-3.66
Accounts Receivable, 3 Yr. CAGR %	-	-	-	140.45	22.34
Inventory, 3 Yr. CAGR %	-	-	-	-29.72	-81.68
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	11.08	-51.85
Total Assets, 3 Yr. CAGR %	-	-	-	12.6	-35.2
Tangible Book Value, 3 Yr. CAGR %	-	-	-	-1.26	-20.68
Common Equity, 3 Yr. CAGR %	-	-	-	-1.15	-21.21
Cash From Operations, 3 Yr. CAGR %	-	-	-	29.07	-0.93
Capital Expenditures, 3 Yr. CAGR %	-	-	-	4.83	-73.15
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	-47.37
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	-63.58